newswire, breaking biotechnology and pharma news

Wednesday, April 26, 2017

Investor Ideas Podcast Corner; Dr. Sarath Malepati, Creator of the EZC Pak Talks about the Growing Antibiotic Resistance Crisis

Investor Ideas Podcast Corner; Dr. Sarath Malepati, Creator of the EZC Pak Talks about the Growing Antibiotic Resistance Crisis

Point Roberts, WA, Delta BC -April 26, 2017 –, a global news source covering biotech and LOHAS,  releases a new Podcast interview with  Dr. Sarath Malepati, a leading expert and creator of the new over the counter supplement EZC Pak which is the first physician formulated immune support pack designed to reduce inappropriate antibiotic use. 

Dr. Sarath Malepati- creator of EZC Pak

To hear more podcasts visit: podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

About - News that Inspires Big Ideas is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.
Sectors we cover in include tech, bitcoin and blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.

The content portfolio goes beyond the site to include 12 blogs on, 7 Artificial Intelligence (AI) websites on the Grid and the, all featuring news and content.

Follow on Twitter!/Investorideas
Follow on Facebook

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

800-665-0411 - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory    Get News Alerts on Biotech Stocks

No comments:

Post a Comment